| Revenue | DKK 0 | — |
| EBITDA | DKK 0 | — |
| Net profit | DKK 0 | — |
| Total assets | DKK 0 | — |
| Equity | DKK -6K | +0% |
| Employees | — | — |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 46 | 70 | 12 | 5 | 8 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -1 | 0 | 0 | 0 | 0 | 46 | 70 | 12 | -1 | 0 | 0 | 0 | 0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -1 | 0 | 0 | 0 | 0 | 46 | 70 | 12 | -1 | 0 | 0 | 0 | 0 |
| Net financials | 0 | 0 | 0 | 0 | 0 | -5 | -50 | -2 | -13 | -2 | 0 | 0 | 0 |
| Profit before tax | -1 | 0 | 0 | 0 | 0 | 41 | 65 | 10 | -14 | -1 | 0 | 0 | 0 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | 8 | 2 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1 | 0 | 0 | 0 | 0 | 41 | 62 | 7 | -14 | -1 | 0 | 0 | 0 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 0 | 0 | 0 | 0 | 0 | 20 | 111 | 73 | 10 | 0 | 0 | 0 | 0 |
| Equity | -100 | -100 | -100 | -100 | -100 | -59 | 3 | 10 | -4 | -6 | -6 | -6 | -6 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 100 | 100 | 100 | 100 | 100 | 79 | 108 | 63 | 14 | 6 | 6 | 6 | 6 |
| Total debt | 100 | 100 | 100 | 100 | 100 | 79 | 108 | 63 | 14 | 6 | 6 | 6 | 6 |
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2021 | |
Alphaa Lab IVS | Company | 100.0% | 100.0% | 2018 |
| Person | Role here | Other companies |
|---|